EDIT vs PH
Editas Medicine Inc (EDIT) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
EDIT currently screens at market cap $375.2M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the EDIT and PH stock pages for the full models.
Not investment advice.